A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...
The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.
A nationwide shortage of BCG vaccines in the country leaves Kenyan newborns vulnerable to TB, a disease with a high ...
Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in protecting monkeys against infection.
An experimental tuberculosis (TB) vaccine with a dual mission – self-destruction after inducing immunity – improved the design of the Bacillus Calmette-Guérin (BCG) immunotherapy, a vaccine also used ...